The Astbury Centre
The Astbury Centre brings together researchers from across the University - largely from physics, the biological sciences and chemistry - to allow interdisciplinary approaches to be harnessed to understand the molecular basis of life. The Centre has outstanding expertise and research infrastructure in chemical biology, biophysics and all of the major techniques in structural molecular biology. Together, these approaches are combined with analyses of biological function with the ultimate aim of understanding the molecular basis of biological mechanisms in living cells.
Our members address major questions associated with biological mechanisms in areas as diverse as membrane proteins; protein folding and assembly; viruses; and motor proteins. The Astbury Centre hosts 4-year PhD programmes funded by the Wellcome Trust and BBSRC that equip students with the wide range of expertise that may be used to address fundamental biological questions.
Download the Astbury Annual Report 2021
Download the Astbury Brochure (produced in 2020)
Visit the Astbury Twitter account for the latest news and announcements.
Yoselin Benitez-Alfonso, from the School of Biology, is celebrating becoming the second person from Leeds to earn a senior promotion after joining the ground-breaking 100 Black Women Professors NOW! programme. The pioneering systemic change programme aims to break down barriers by increasing the number of Black women in the academic pipeline. When it was launched in 2021,...
For the first time, scientists have witnessed new molecular behaviour in proteins that protect us from cancer. Scientists in the have identified new features of BRCA1–BARD1, a group of proteins that play a critical role in repairing damaged DNA. Using ground-breaking imaging techniques, thanks to the state-of-the-art equipment at the Astbury and Bragg centres in the...
Scientists discover promising new way to personalise treatment for patients with cancer and autoimmune diseases
Researchers at the University of Leeds have developed a new diagnostic approach that can quickly identify how a patient is responding to antibody medication. The technology, which uses special sensors called enzyme switch sensors, can detect the amount of therapeutic monoclonal antibodies (TmAb) that are present in a patient’s system. TmAbs are medicines that are...